CDT (STOCKS)
CDT Equity Inc. Common Stock
$4.960000
+0.880000 (+21.57%)
Prev close: $4.080000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Andrew Regan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $23.19M
- Employees
- 6
- P/E (TTM)
- —
- P/B (TTM)
- 0.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$1.19M |
| Operating Expenses | $19.51M |
| Research and Development | $4.44M |
| Other Operating Expenses | $14.67M |
| Operating Income/Loss | -$19.11M |
| Income/Loss From Continuing Operations After Tax | -$17.30M |
| Income/Loss From Continuing Operations Before Tax | -$20.31M |
| Net Income/Loss | -$20.31M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$20.31M |
| Net Income/Loss Available To Common Stockholders, Basic | -$20.31M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.32K |
| Diluted Earnings Per Share | $2.32K |
| Basic Average Shares | 6,390,655 |
| Diluted Average Shares | 6,390,655 |
| Assets | $8.55M |
| Current Assets | $7.09M |
| Noncurrent Assets | $1.46M |
| Fixed Assets | $325.00K |
| Other Non-current Assets | $1.13M |
| Liabilities | $4.27M |
| Current Liabilities | $4.27M |
| Accounts Payable | $613.00K |
| Other Current Liabilities | $3.65M |
| Noncurrent Liabilities | $9.00K |
| Equity | $4.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.28M |
| Liabilities And Equity | $8.55M |
| Net Cash Flow From Operating Activities | -$14.73M |
| Net Cash Flow From Operating Activities, Continuing | -$14.73M |
| Net Cash Flow From Investing Activities | -$1.32M |
| Net Cash Flow From Investing Activities, Continuing | -$1.32M |
| Net Cash Flow From Financing Activities | $19.89M |
| Net Cash Flow From Financing Activities, Continuing | $19.89M |
| Net Cash Flow | $3.84M |
| Net Cash Flow, Continuing | $3.84M |
| Comprehensive Income/Loss | -$20.36M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$20.36M |
| Other Comprehensive Income/Loss | -$20.36M |